Archives
ACAAI: ICS + Formoterol and ICS + SABA Better Than SABA Alone for Asthma
Inhaled corticosteroid with short-acting β agonists or long-acting β agonist formoterol linked to reduction in exacerbations, improved control
ACS: Many Cancer Patients Face Lasting Financial Difficulties
Patients with cancer have higher rates of total collections, medical collections, and bankruptcy
ACAAI: 2013 to 2023 Saw Rise in Pediatric Psych Referrals Tied to Food Allergies
During the study period, there was an 11-fold increase in food allergy-related referrals
ASN: Recurrent UTIs Impact eGFR in Children With Vesicoureteral Reflux
Recurrent urinary tract infections linked to decrease of up to 27 mL/min/1.73 m² in estimated glomerular filtration rate
ACG: Fewer Overt Hepatic Encephalopathy Episodes Seen With Rifaximin
Rifaximin monotherapy reduces risk for breakthrough OHE episode and results in a lower mortality rate than lactulose monotherapy
ASN: Empagliflozin Offers Lasting Cardiorenal Benefit in CKD Patients
Empagliflozin offers cardiorenal benefits for up to 12 months after discontinuation among CKD patients at risk for progression
ACAAI: Most Syphilis Patients With Penicillin Allergy Have Low Risk for Severe Allergy
Authors call for aggressively delabeling these patients to avoid treatment failure
ACAAI: Many Anaphylaxis Protocols Are Incomplete, Outdated
Second study shows that only 14 percent of patients correctly identified symptoms requiring epinephrine
ASA: Risk for Postoperative Delirium Increased With Poor and Worsening Sleep
Significantly higher chance of experiencing delirium seen for those with worsening of their PSQI over three scores
ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary Angioedema
Reduction of 75 and 77 percent seen in estimated mean monthly attack rate with 25-mg, 50-mg NTLA-2002 versus placebo